News archive
Programme Contacts
University of Cambridge
Department of Haematology
Programme Lead
Wellcome Trust Sanger Institute, University of Cambridge
Department of Haematology
Programme Lead
University of Cambridge
Department of Haematology
Training Lead
University of Cambridge
Department of Haematology, Wellcome Trust MRC Cambridge Stem Cell Institute
Programme Manager
Scientists develop test to identify people at risk of developing acute myeloid leukaemia and related cancers
24 Aug 2023
The new platform, called ‘MN-predict’, will allow doctors and scientists to identify those at risk and to design new treatments to prevent them from developing these potentially lethal cancers.
Junior Investigators attend Leicester meeting
8 Feb 2023
Annual Junior Investigators Network Group meeting held in Leicester on 6 and 7 Feb 2023
Fellows of the Academy of Medical Sciences 2021
12 May 2021
Four Centre members join 50 outstanding biomedical and health scientists elected to the prestigious Academy of Medical Sciences Fellowship for 2021.
Fellows of The Royal Society 2021
6 May 2021
Congratulations to Professor Julie Ahringer, Dr Peter Campbell, Professor David Rowitch and Professor Ben Simons on their election as Fellows of the Royal Society.
Potential new type of cancer drug to treat leukaemia
26 Apr 2021
Scientists have made a promising step towards developing a new drug for treating acute myeloid leukaemia, a rare blood disorder.
Collaborative COVID-19 study reveals variation in immune response
20 Apr 2021
Haematological Malignancies programme members are part of a team who have found raised levels of specific immune cells in asymptomatic people with COVID-19.
CAR-T cell therapy available in east of England
12 Nov 2020
Addenbrooke’s becomes first regional centre to offer CAR-T cell treatment for cancer patients.
Uncovering network control of blood cell production
26 Oct 2020
Haematological Malignancies Programme members identify new functional links in blood cell production network
Spinout company Stroma Biosciences selected to take place in Accelerate@Babraham Start-up Programme
22 Sep 2020
Spinout company Stroma Biosciences, co-founded by Dr Ingo Ringshausen and post-doc Dr Eugene Park has been selected as one of four start-up companies taking part in the Accelerate@Babraham Start-up Programme
Towards precision medicine: Funding awarded from the Rosetrees Trust for project focussing on patients with myeloid stem cell cancers
30 Jul 2020
Dr Jyoti Nangalia has been awarded funding from the Rosetrees Trust for her project “Towards precision medicine: Integrating personalised prognostic predictions for patients with myeloid stem cell cancers into clinical care.”
